Skip to content

Drug interactions

Denosumab + Nelarabine

Severity: Moderate

Denosumab and Nelarabine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nelarabine causes myelosuppression and immune impairment, and denosumab labeling warns of serious infections in immunocompromised patients. The combined risk of infection may be higher, although no specific interaction data exist.

What this interaction means in plain words

Denosumab and Nelarabine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Denosumab belongs to Oncology; Nelarabine belongs to Oncology.

Evidence level: Low

Why it happens

Additive infection risk from chemotherapy-induced myelosuppression and possible immune effects of denosumab.

What to do

Monitor blood counts and watch for infection. Treat suspected infection promptly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Denosumab and Nelarabine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Denosumab with Nelarabine?

MediHelp rates the interaction as moderate. Denosumab and Nelarabine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nelarabine causes myelosuppression and immune impairment, and denosumab labeling warns of serious infections in immunocompromised patients. The combined risk of infection may be higher, although no specific interaction data exist.

How serious is the interaction between Denosumab and Nelarabine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and watch for infection. Treat suspected infection promptly.

What other medicines interact with Denosumab?

MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in